Photo of Zach Klaassen from X
May 8, 2024, 07:32
Zach Klaassen: Survey on using intravesical chemo for BCG unresponsive NMIBC
Zach Klaassen, Urology Oncologist at Georgia Cancer Center, shared on X: .
“Survey on clinical practice patterns in USA for using intravesical chemotherapy for BCG unresponsive Non—muscle-invasive Bladder Cancer (NMIBC).
- 159 urologists who treat CIS; 100 urologists who treat papillary-only tumors
- CIS rank order: Gem: 40%, MMC: 28%, Val: 19%, Gem/Doce: 8%, Other: 5%
- Papillary rank order: Gem: 49%, MMC: 23%, Gem/Doce: 15%, Val: 11%, Other: 2%”
Source: Zach Klaassen/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 14:06
Dec 21, 2024, 13:46
Dec 21, 2024, 13:40
Dec 21, 2024, 13:33